Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
RECRUITINGPhase 3NCT07377643
IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer
This is a randomized, multicenter, open-label, phase 3 study evaluating the efficacy, safety, and tolerability of IBI354 combined with or without pertuzumab vs. THP as first-line...
Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.Enrolling: 5401 location
HER2-positive Breast Cancer
RECRUITINGPhase 2 / Phase 3NCT07295509
A Study of Picankibart in Patients With Active Psoriatic Arthritis
This is a multicenter, randomized, double-blind, placebo-controlled Phase II/III clinical trial evaluating the efficacy and safety of picankibart (IBI112) in patients with active...
Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.Enrolling: 2221 location
Psoriatic Arthritis